Virax Biolabs Group Ltd Adjustments For Share-based Payments
Virax Biolabs Group Ltd (VRAX) reported Adjustments For Share-based Payments of $365.31 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2025-07-02
| Period end | Adjustments For Share-based Payments 12 month |
|---|---|
| 2025-03-31 | $365.31K 20-F · filed 2025-07-02 |
| 2024-03-31 | $1.01M 20-F · filed 2025-07-02 |
| 2023-03-31 | $1.73M 20-F · filed 2025-07-02 |
| 2022-03-31 | $290.36K 20-F · filed 2022-08-12 |